Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tuberculosis
Biotech
Novo Nordisk Foundation sets up $260M vaccine initiative
The Novo Nordisk Foundation is dedicating up to $260 million to create new or improved vaccines for serious respiratory diseases.
Gabrielle Masson
Dec 18, 2023 11:14am
Siemens Healthineers, Qure partner on X-ray AI for TB screening
Oct 16, 2023 2:59pm
2 foundations pour $550M into phase 3 for ex-GSK TB shot
Jun 29, 2023 11:18am
GSK antibiotics strategy scores 2nd win this month with TB data
Nov 15, 2022 10:15am
BioNTech lines up 5 infectious disease trials for 2023
Nov 7, 2022 6:57am
Bill & Melinda Gates research arm picks up 2 Merck TB candidates
Oct 18, 2022 11:00am